• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于临床的快速灵敏的显色肝素检测方法的开发。

Development of a rapid and sensitive chromogenic heparin assay for clinical use.

作者信息

Wagenvoord R J, Hendrix H H, Kolde H J, Hemker H C

机构信息

Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.

出版信息

Haemostasis. 1993;23(1):26-37. doi: 10.1159/000216849.

DOI:10.1159/000216849
PMID:8477906
Abstract

A new sensitive chromogenic heparin assay is developed, which is well suited for clinical use. For the assay two reaction mixtures are required which can be lyophilized and reconstituted on the day of use. These reagents are stable during at least 6 h. Only two time-dependent pipetting steps are necessary. Any compound that inactivates thrombin, or can potentiate thrombin inactivation by an inhibitor, can be measured with this assay, including standard heparin, low molecular weight heparins, hirudin, alpha-NAPAP, pentosan polysulphate and dermatan sulphate. It is shown that heparin can be measured accurately in whole blood and in plasma. By addition of dextran sulphate to one of the reagents a platelet factor 4-insensitive assay is developed, so heparin can be measured even in blood that is partially activated and thus contains platelet factor 4 which neutralizes heparin.

摘要

开发了一种新型灵敏的显色肝素测定法,非常适合临床使用。该测定法需要两种反应混合物,它们可以冻干并在使用当天复溶。这些试剂至少在6小时内稳定。仅需两个与时间相关的移液步骤。任何能使凝血酶失活或可增强抑制剂对凝血酶失活作用的化合物都可以用该测定法进行测量,包括标准肝素、低分子量肝素、水蛭素、α-萘丙酰基精氨酸乙酯、戊聚糖多硫酸盐和硫酸皮肤素。结果表明,肝素可以在全血和血浆中准确测量。通过向其中一种试剂中添加硫酸葡聚糖,开发了一种对血小板因子4不敏感的测定法,因此即使在部分激活的血液中(因而含有中和肝素的血小板因子4)也可以测量肝素。

相似文献

1
Development of a rapid and sensitive chromogenic heparin assay for clinical use.用于临床的快速灵敏的显色肝素检测方法的开发。
Haemostasis. 1993;23(1):26-37. doi: 10.1159/000216849.
2
Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine.凝血因子Xa检测试剂中含有的硫酸葡聚糖会高估鱼精蛋白逆转肝素作用后患者体内的肝素活性。
Thromb Res. 2003;111(4-5):273-9. doi: 10.1016/j.thromres.2003.09.014.
3
Automated determination of heparin with chromogenic substrates.用显色底物自动测定肝素。
Haemostasis. 1984;14(2):184-94. doi: 10.1159/000215055.
4
Mechanisms for the anticoagulant effect of heparin and related polysaccharides.肝素及相关多糖的抗凝作用机制。
Nouv Rev Fr Hematol (1978). 1988;30(3):155-60.
5
Measurement of antithrombin activity by thrombin-based and by factor Xa-based chromogenic substrate assays.通过基于凝血酶和基于因子Xa的显色底物测定法测量抗凝血酶活性。
Blood Coagul Fibrinolysis. 2000 Mar;11(2):127-35.
6
Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.抗凝血酶III和肝素辅因子II在体内对凝血酶的抑制作用。
Thromb Haemost. 1995 Mar;73(3):405-12.
7
Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.人血浆中硫酸皮肤素辅因子(肝素辅因子II)活性的测定。
Thromb Res. 1984 Aug 1;35(3):257-66. doi: 10.1016/0049-3848(84)90357-8.
8
Modification of an amidolytic heparin assay to express protein-bound heparin and to correct for the effect of antithrombin III concentration.对一种酰胺分解肝素测定法进行改良,以表达与蛋白质结合的肝素,并校正抗凝血酶III浓度的影响。
Thromb Haemost. 1987 Oct 28;58(3):884-7.
9
Low-affinity material does not contribute to the antithrombotic activity of Orgaran (Org 10172) in human plasma.低亲和力物质对去纤苷(Org 10172)在人血浆中的抗血栓活性无贡献。
Thromb Haemost. 1994 Jun;71(6):759-67.
10
An improved heparin assay which is insensitive to platelet factor 4.一种对血小板第4因子不敏感的改良肝素测定法。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(6):873-8.

引用本文的文献

1
Optimization of Heparin Monitoring with Anti-FXa Assays and the Impact of Dextran Sulfate for Measuring All Drug Activity.使用抗Xa因子测定法优化肝素监测以及硫酸葡聚糖对测量所有药物活性的影响。
Biomedicines. 2021 Jun 21;9(6):700. doi: 10.3390/biomedicines9060700.
2
Heparins: A Shift of Paradigm.肝素:范式的转变。
Front Med (Lausanne). 2019 Nov 15;6:254. doi: 10.3389/fmed.2019.00254. eCollection 2019.